Chase Investment Counsel’s Halozyme HALO Stock Holding History

Chase Investment Counsel’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.04M	Hold	26,000	–	–	0.43%	46
2026 Q1	$1.68M	Hold	26,000	–	–	0.44%	52
2025 Q4	$1.75M	Hold	26,000	–	–	0.49%	48
2025 Q3	$1.91M	Hold	26,000	–	–	0.56%	48
2025 Q2	$1.35M	Hold	26,000	–	–	0.43%	57
2025 Q1	$1.66M	Sell	26,000 -691	-3%	-$40.1K	0.61%	50
2024 Q4	$1.28M	Sell	26,691 -66,910	-71%	-$3.43M	0.41%	58
2024 Q3	$5.36M	Buy	93,601 +2,264	+2%	+$130K	1.78%	20
2024 Q2	$4.78M	Buy	+91,337	New	+$4.01M	1.7%	17

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Chase Investment Counsel's HALO Position: Q2 2026 in Review

Chase Investment Counsel held its Halozyme (HALO) position steady in Q2 2026 at 26,000 shares worth $2.04M. The position accounts for 0.43% of the portfolio, ranked #46.

Chase Investment Counsel first reported a position in HALO in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.36M in Q3 2024. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Chase Investment Counsel held 26,000 shares of Halozyme worth $2.04M as of Q2 2026.
Chase Investment Counsel left its Halozyme share count unchanged in Q2 2026.
Halozyme made up 0.43% of Chase Investment Counsel's portfolio in Q2 2026, its #46 holding.
Chase Investment Counsel first reported a position in Halozyme in Q2 2024 and has held it in 9 quarters since.
Chase Investment Counsel's Halozyme position peaked at $5.36M in Q3 2024.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Chase Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.